Express News | Iteos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 a2a-005 Clinical Trial Data in 2L Nsclc at Esmo Immuno-Oncology Congress

ReutersOct 24 07:00 ET

ITeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress

GlobeNewswireOct 24 07:00 ET

We're Keeping An Eye On ITeos Therapeutics' (NASDAQ:ITOS) Cash Burn Rate

Simply Wall StSep 18 09:01 ET

ITeos Therapeutics Down Over 29%, on Pace for Largest Percent Decrease Since May 2022 -- Data Talk

Dow JonesSep 16 11:43 ET

ITeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session

BenzingaSep 16 08:44 ET

Market-Moving News for September 16th

BenzingaSep 16 08:08 ET